JCB logo
PeproTech: Cell Culture Supplements
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 206K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schapiro, F.
Right arrow Articles by Grinstein, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schapiro, F.
Right arrow Articles by Grinstein, S.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

© The Rockefeller University Press, 0021-9525/2000//305 $5.00
The Journal of Cell Biology, Volume 148, Number 2, , 2000 305-316

Original Article

Golgi Alkalinization by the Papillomavirus E5 Oncoprotein



Florencia Schapiroa,b, Jason Sparkowskic, Alex Adducic, Frank Suprynowiczc, Richard Schlegelc, and Sergio Grinsteina,b

a Division of Cell Biology, Research Institute, Hospital for Sick Children, Toronto, Ontario, M5G 1X8 Canada
b Department of Biochemistry, University of Toronto, Toronto, Ontario, M5S 1A8 Canada
c Department of Pathology, Georgetown University Medical Center, Washington, DC
Division of Cell Biology Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, M5G 1X8 Canada.(416) 813-5028(416) 813-5727

sga{at}sickkids.on.ca

The E5 oncoprotein of bovine papillomavirus type I is a small, hydrophobic polypeptide localized predominantly in the Golgi complex. E5-mediated transformation is often associated with activation of the PDGF receptor (PDGF-R). However, some E5 mutants fail to induce PDGF-R phosphorylation yet retain transforming activity, suggesting an additional mechanism of action. Since E5 also interacts with the 16-kD pore-forming subunit of the vacuolar H+-ATPase (V-ATPase), the oncoprotein could conceivably interfere with the pH homeostasis of the Golgi complex. A pH-sensitive, fluorescent bacterial toxin was used to label this organelle and Golgi pH (pHG) was measured by ratio imaging. Whereas pHG of untreated cells was acidic (6.5), no acidification was detected in E5-transfected cells (pH ~7.0). The Golgi buffering power and the rate of H+ leakage were found to be comparable in control and transfected cells. Instead, the E5-induced pH differential was attributed to impairment of V-ATPase activity, even though the amount of ATPase present in the Golgi complex was unaltered. Mutations that abolished binding of E5 to the 16-kD subunit or that targeted the oncoprotein to the endoplasmic reticulum abrogated Golgi alkalinization and cellular transformation. Moreover, transformation-competent E5 mutants that were defective for PDGF-R activation alkalinized the Golgi lumen. Neither transformation by sis nor src, two oncoproteins in the PDGF-R signaling pathway, affected pHG. We conclude that alkalinization of the Golgi complex represents a new biological activity of the E5 oncoprotein that correlates with cellular transformation.

Key Words: vesicular traffic • pH regulation • cholera toxin • proton pump • V-ATPase

© 2000 The Rockefeller University Press

Abbreviations used in this paper: BPV, bovine papillomavirus; PDGF-R, PDGF receptor; pHG, Golgi pH; PV, papillomavirus; V-ATPase, vacuolar H+-ATPase.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents